G2019S mutation in the leucine‐rich repeat kinase 2 gene is not associated with multiple system atrophy
- 15 March 2007
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 22 (4) , 546-549
- https://doi.org/10.1002/mds.21343
Abstract
Multiple system atrophy (MSA) is characterized clinically by Parkinsonism, cerebellar dysfunction, and autonomic impairment. Multiple mutations in the LRRK2 gene are associated with parkinsonian disorders, and the most common one, the G2019S mutation, has been found in ∼1% of sporadic cases of Parkinsonism. In a well-characterized cohort of 136 subjects with probable MSA and 110 neurologically evaluated control subjects, none carried the G2019S mutation. We conclude that the G2019S mutation in the LRRK2 gene is unlikely to be associated with MSA. © 2007 Movement Disorder SocietyKeywords
This publication has 25 references indexed in Scilit:
- Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementiaNeuroscience Letters, 2006
- Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late‐onset Parkinson's diseaseMovement Disorders, 2006
- LRRK2 mutations are not common in Alzheimer's diseaseMechanisms of Ageing and Development, 2005
- The European Multiple System Atrophy-Study Group (EMSA-SG)Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2005
- Genetic screening for a single common LRRK2 mutation in familial Parkinson's diseaseThe Lancet, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Progression and prognosis in multiple system atrophyBrain, 2002
- Comparison of natural histories of progressive supranuclear palsy and multiple system atrophyNeurological Sciences, 2001
- Multiple system atrophyCurrent Opinion in Neurology, 1995
- Clinical features and natural history of multiple system atrophyBrain, 1994